0
Skip to Content
Auransa
PLATFORM
PIPELINE OVERVIEW
AU409 at AACR
AU409 SCIENCE
PARTNERS
ABOUT US
LEADERSHIP
PRESS
PUBLICATIONS
CONTACT
Auransa
PLATFORM
PIPELINE OVERVIEW
AU409 at AACR
AU409 SCIENCE
PARTNERS
ABOUT US
LEADERSHIP
PRESS
PUBLICATIONS
CONTACT
PLATFORM
Folder: PIPELINE
Back
PIPELINE OVERVIEW
AU409 at AACR
AU409 SCIENCE
PARTNERS
Folder: COMPANY
Back
ABOUT US
LEADERSHIP
Folder: MEDIA
Back
PRESS
PUBLICATIONS
CONTACT
Jingyu Guo 7/29/26 Jingyu Guo 7/29/26

AACR 2026: Early Clinical Activity and Tumor Transcriptional Modulation of AU409, a First-in-Class Transcription Regulator, in Advanced Solid Tumors and Hepatocellular Carcinoma

Read More
Yolandi Stanek 11/5/22 Yolandi Stanek 11/5/22

Elucidating host cell response pathways and repurposing therapeutics for SARS-CoV-2 and other coronaviruses

Read More
Yolandi Stanek 4/19/21 Yolandi Stanek 4/19/21

Using AI to embrace patient heterogeneity

Read More
Yolandi Stanek 8/1/20 Yolandi Stanek 8/1/20

Development of the digital arthritis index for rheumatoid arthritis

Read More
Yolandi Stanek 11/1/19 Yolandi Stanek 11/1/19

Discovery of a cardioprotective compound for patients undergoing chemotherapy

Read More
Yolandi Stanek 9/23/19 Yolandi Stanek 9/23/19

Mitigating gastrointestinal toxicity due to PI3K inhibitors

Read More
Yolandi Stanek 1/3/19 Yolandi Stanek 1/3/19

Auransa’s AI-Predicted Pipeline

Read More

© 2026 Auransa Inc. All rights reserved.

Auransa is committed to protecting and respecting your privacy. We don't collect personal data and we don't use cookies to collect personally identifiable information about visitors to this website.